Blackstone group invests up to $2 billion in alnylam, a big bet on the cambridge biotech

Statnews

Blackstone group invests up to $2 billion in alnylam, a big bet on the cambridge biotech"


Play all audios:

Loading...

The private equity firm Blackstone Group is investing up to $2 billion in Alnylam Pharmaceuticals, a big bet on the Cambridge biotech’s approach to developing drugs for genetic diseases and


disorders that need better treatments. The deal, which was announced Monday, is anchored by Blackstone’s purchase of half the royalties owed to Alnylam on global sales of inclisiran, an


experimental RNA interference drug for the treatment of high cholesterol. Inclisiran is a twice-a-year injected RNAi therapeutic that reduced bad cholesterol in a late-stage clinical trial.


If approved, the medicine is expected to help reduce a major risk factor for cardiovascular disease, the leading global cause of death, according to Alnylam. STAT+ Exclusive Story Already


have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — PLUS DAILY COVERAGE AND ANALYSIS OF THE BIOTECH SECTOR — BY SUBSCRIBING TO STAT+. Already have an


account? Log in Individual plans Group plans View All Plans To read the rest of this story subscribe to STAT+. Subscribe


Trending News

The aarp minute: november 13, 2023

Memorial Day Sale! Join AARP for just $11 per year with a 5-year membership Join now and get a FREE gift. Expires 6/4  G...

Who belongs in america? An undocumented journalist tells his story

[embedded content] PART 1 OF _TED RADIO HOUR _ EPISODE _WHAT TOPPLES DEMOCRACIES_. At 16, Jose Antonio Vargas learned he...

CNN Profiles | CNN

CNN values your feedback 1. How relevant is this ad to you? 2. Did you encounter any technical issues? Video player was ...

Editorial cartoon u. S. Bitcoin crypto currency is the norm

SIGN UP FOR THE WEEK'S FREE NEWSLETTERS From our morning news briefing to a weekly Good News Newsletter, get the be...

You Need to Know These Estate Planning Terms

1:05 Videos de AARP You Need to Know These Estate Planning Terms Facebook Twitter LinkedIn Knowing the right terms when ...

Latests News

Blackstone group invests up to $2 billion in alnylam, a big bet on the cambridge biotech

The private equity firm Blackstone Group is investing up to $2 billion in Alnylam Pharmaceuticals, a big bet on the Camb...

Javascript support required...

Interview: sailor sam goodchild prepares for vendée globe round-world solo race

Update November 24: Sam Goodchild is in third place in the Vendée Globe race. It is estimated to last until the last wee...

Radiographic artefacts produced by static electricity

ARTICLE PDF Authors * R J Edler View author publications You can also search for this author inPubMed Google Scholar RIG...

Plans for 80-year d-day commemorations in normandy and provence

EVENTS WILL ALSO PAY HOMAGE TO RESISTANCE FIGHTERS A dozen ‘major’ events and thousands of smaller local ones are to be ...

Top